Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors

Epithelial–mesenchymal transition (EMT) is a driving force for tumor growth, metastatic spread, therapy resistance, and the generation of cancer stem cells (CSCs). However, the regained stem cell character may also be exploited for therapeutic conversion of aggressive tumor cells to benign, highly d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paula Marie Schmidtlein, Clara Volz, Alexander Hackel, Isabel Thürling, Darko Castven, Rüdiger Braun, Ulrich Friedrich Wellner, Björn Konukiewitz, Gabriela Riemekasten, Hendrik Lehnert, Jens-Uwe Marquardt, Hendrik Ungefroren
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/9942266632504c8d88bf3c4bd7f07b0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9942266632504c8d88bf3c4bd7f07b0a
record_format dspace
spelling oai:doaj.org-article:9942266632504c8d88bf3c4bd7f07b0a2021-11-11T15:34:21ZActivation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors10.3390/cancers132155412072-6694https://doaj.org/article/9942266632504c8d88bf3c4bd7f07b0a2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5541https://doaj.org/toc/2072-6694Epithelial–mesenchymal transition (EMT) is a driving force for tumor growth, metastatic spread, therapy resistance, and the generation of cancer stem cells (CSCs). However, the regained stem cell character may also be exploited for therapeutic conversion of aggressive tumor cells to benign, highly differentiated cells. The PDAC-derived quasimesenchymal-type cell lines PANC-1 and MIA PaCa-2 have been successfully transdifferentiated to endocrine precursors or insulin-producing cells; however, the underlying mechanism of this increased plasticity remains elusive. Given its crucial role in normal pancreatic endocrine development and tumor progression, both of which involve EMT, we analyzed here the role of the small GTPase RAC1. Ectopic expression in PANC-1 cells of dominant negative or constitutively active mutants of RAC1 activation blocked or enhanced, respectively, the cytokine-induced activation of a ductal-to-endocrine transdifferentiation transcriptional program (deTDtP) as revealed by induction of the NEUROG3, INS, SLC2A2, and MAFA genes. Conversely, ectopic expression of RAC1b, a RAC1 splice isoform and functional antagonist of RAC1-driven EMT, decreased the deTDtP, while genetic knockout of RAC1b dramatically increased it. We further show that inhibition of RAC1 activation attenuated pluripotency marker expression and self-renewal ability, while depletion of RAC1b dramatically enhanced stemness features and clonogenic potential. Finally, rescue experiments involving pharmacological or RNA interference-mediated inhibition of RAC1 or RAC1b, respectively, confirmed that both RAC1 isoforms control the deTDtP in an opposite manner. We conclude that RAC1 and RAC1b antagonistically control growth factor-induced activation of an endocrine transcriptional program and the generation of CSCs in quasimesenchymal PDAC cells. Our results have clinical implications for PDAC patients, who in addition to eradication of tumor cells have a need for replacement of insulin-producing cells.Paula Marie SchmidtleinClara VolzAlexander HackelIsabel ThürlingDarko CastvenRüdiger BraunUlrich Friedrich WellnerBjörn KonukiewitzGabriela RiemekastenHendrik LehnertJens-Uwe MarquardtHendrik UngefrorenMDPI AGarticlepancreatic ductal adenocarcinomaPANC-1quasimesenchymalductal-to-endocrine transdifferentiationpancreatic β cellstemnessNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5541, p 5541 (2021)
institution DOAJ
collection DOAJ
language EN
topic pancreatic ductal adenocarcinoma
PANC-1
quasimesenchymal
ductal-to-endocrine transdifferentiation
pancreatic β cell
stemness
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle pancreatic ductal adenocarcinoma
PANC-1
quasimesenchymal
ductal-to-endocrine transdifferentiation
pancreatic β cell
stemness
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Paula Marie Schmidtlein
Clara Volz
Alexander Hackel
Isabel Thürling
Darko Castven
Rüdiger Braun
Ulrich Friedrich Wellner
Björn Konukiewitz
Gabriela Riemekasten
Hendrik Lehnert
Jens-Uwe Marquardt
Hendrik Ungefroren
Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
description Epithelial–mesenchymal transition (EMT) is a driving force for tumor growth, metastatic spread, therapy resistance, and the generation of cancer stem cells (CSCs). However, the regained stem cell character may also be exploited for therapeutic conversion of aggressive tumor cells to benign, highly differentiated cells. The PDAC-derived quasimesenchymal-type cell lines PANC-1 and MIA PaCa-2 have been successfully transdifferentiated to endocrine precursors or insulin-producing cells; however, the underlying mechanism of this increased plasticity remains elusive. Given its crucial role in normal pancreatic endocrine development and tumor progression, both of which involve EMT, we analyzed here the role of the small GTPase RAC1. Ectopic expression in PANC-1 cells of dominant negative or constitutively active mutants of RAC1 activation blocked or enhanced, respectively, the cytokine-induced activation of a ductal-to-endocrine transdifferentiation transcriptional program (deTDtP) as revealed by induction of the NEUROG3, INS, SLC2A2, and MAFA genes. Conversely, ectopic expression of RAC1b, a RAC1 splice isoform and functional antagonist of RAC1-driven EMT, decreased the deTDtP, while genetic knockout of RAC1b dramatically increased it. We further show that inhibition of RAC1 activation attenuated pluripotency marker expression and self-renewal ability, while depletion of RAC1b dramatically enhanced stemness features and clonogenic potential. Finally, rescue experiments involving pharmacological or RNA interference-mediated inhibition of RAC1 or RAC1b, respectively, confirmed that both RAC1 isoforms control the deTDtP in an opposite manner. We conclude that RAC1 and RAC1b antagonistically control growth factor-induced activation of an endocrine transcriptional program and the generation of CSCs in quasimesenchymal PDAC cells. Our results have clinical implications for PDAC patients, who in addition to eradication of tumor cells have a need for replacement of insulin-producing cells.
format article
author Paula Marie Schmidtlein
Clara Volz
Alexander Hackel
Isabel Thürling
Darko Castven
Rüdiger Braun
Ulrich Friedrich Wellner
Björn Konukiewitz
Gabriela Riemekasten
Hendrik Lehnert
Jens-Uwe Marquardt
Hendrik Ungefroren
author_facet Paula Marie Schmidtlein
Clara Volz
Alexander Hackel
Isabel Thürling
Darko Castven
Rüdiger Braun
Ulrich Friedrich Wellner
Björn Konukiewitz
Gabriela Riemekasten
Hendrik Lehnert
Jens-Uwe Marquardt
Hendrik Ungefroren
author_sort Paula Marie Schmidtlein
title Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
title_short Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
title_full Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
title_fullStr Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
title_full_unstemmed Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
title_sort activation of a ductal-to-endocrine transdifferentiation transcriptional program in the pancreatic cancer cell line panc-1 is controlled by rac1 and rac1b through antagonistic regulation of stemness factors
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/9942266632504c8d88bf3c4bd7f07b0a
work_keys_str_mv AT paulamarieschmidtlein activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT claravolz activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT alexanderhackel activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT isabelthurling activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT darkocastven activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT rudigerbraun activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT ulrichfriedrichwellner activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT bjornkonukiewitz activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT gabrielariemekasten activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT hendriklehnert activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT jensuwemarquardt activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
AT hendrikungefroren activationofaductaltoendocrinetransdifferentiationtranscriptionalprograminthepancreaticcancercelllinepanc1iscontrolledbyrac1andrac1bthroughantagonisticregulationofstemnessfactors
_version_ 1718435197458841600